MyAverix Finance
US · Healthcare
Mineralys Therapeutics, Inc. Common Stock (MLYS)
Biotechnology
Mineralys Therapeutics, Inc. Common Stock (MLYS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MLYS
Mineralys Therapeutics, Inc. Common Stock (MLYS) — FAQ
What is MLYS's P/E ratio?
The price-to-earnings (P/E) ratio for Mineralys Therapeutics, Inc. Common Stock (MLYS) is 25.00 (data as of 2026-05-23).
Does Mineralys Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Mineralys Therapeutics, Inc. Common Stock (MLYS). Check the MyAverix Finance app for the latest dividend data.
What sector is Mineralys Therapeutics, Inc. Common Stock in?
Mineralys Therapeutics, Inc. Common Stock (MLYS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MLYS listed on?
MLYS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.